Status:
COMPLETED
REMINDer - A Digital Environmental Enrichment Intervention
Lead Sponsor:
German Center for Neurodegenerative Diseases (DZNE)
Conditions:
Healthy
Eligibility:
All Genders
60-80 years
Phase:
NA
Brief Summary
The primary goal of this pilot study is to assess the feasibility and effectiveness for improving overall mental and physical well-being of a multimodal intervention program in older adults carried ou...
Detailed Description
Background: Increasing life expectancy and associated age-related diseases, such as Alzheimer's disease, are considered a global challenge for society. Multiple physical, cognitive, and psychosocial r...
Eligibility Criteria
Inclusion
- Retired adults aged between 60 and 80 years
- Fluency in the German language
- Cognitively unimpaired, as assessed via the Six-Item Screener (SIS) ≥ 4 points (out of 6)
- Access to wireless internet connection and a digital device with speakers, screen, and camera at home
- Access to a personal email address
- Sufficient in-home space
- Availability throughout the study and its measurement time points
- Ability to provide written informed consent
- Spouses (must be in the same group and each participate in the intervention individually via their own device and in independent rooms; this fact is considered accordingly in the analyses)
Exclusion
- Regular rigorous physical exercise as defined by regular aerobic exercise (\> 1.5 hours/week) during the last 6 months
- Regular prior experience (\> 1 hour/week) with tai chi, dance-movement, or other mind-body practices during the last 6 months
- Disabilities that limit participation in online moment programs: Presence of physical ineligibility or mobility restrictions through a history of falls, not being able to walk, reliance on a walking aid
- Severe uncorrected auditory or visual impairments that limit the ability to listen to online instructions or to observe online movements
- Diagnosis of cognitive impairment and any type of dementia
- Diagnosis of motor disorders (e.g. Parkinson's disease, multiple sclerosis)
- History of cerebral disease (e.g. tumor)
- Severe neurological disorders (e.g. epilepsy)
- Diagnosis of psychiatric disorders (e.g. depression)
- Other chronic medical disorders that limit physical activity (e.g. advanced cardiac or respiratory disease, severe hypertension)
- Substance abuse (excessive smoking, alcohol consumption, drug abuse)
- Current participation in another research study
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 13 2024
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT06530277
Start Date
August 1 2024
End Date
December 13 2024
Last Update
February 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
German Center for Neurodegenerative Diseases (DZNE), Dresden
Dresden, Saxony, Germany, 01307